David Avarbock

1.5k total citations
8 papers, 1.2k citations indexed

About

David Avarbock is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, David Avarbock has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in David Avarbock's work include Tuberculosis Research and Epidemiology (6 papers), Bacterial Genetics and Biotechnology (4 papers) and RNA and protein synthesis mechanisms (3 papers). David Avarbock is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Bacterial Genetics and Biotechnology (4 papers) and RNA and protein synthesis mechanisms (3 papers). David Avarbock collaborates with scholars based in United States and South Africa. David Avarbock's co-authors include Harvey Rubin, Valerie Mizrahi, Clifton E. Barry, Andrew Avarbock, Susan J. Andersen, Todd P. Primm, Edward A. Weinstein, Zhimei Wang, John L. Dahl and Helena I. Boshoff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Journal of Bacteriology.

In The Last Decade

David Avarbock

8 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Avarbock United States	8	686	675	529	265	246	8	1.2k
Philip Draper United Kingdom	11	783 1.1×	461 0.7×	747 1.4×	139 0.5×	152 0.6×	12	1.1k
Stephanie S. Dawes South Africa	14	659 1.0×	652 1.0×	465 0.9×	115 0.4×	181 0.7×	19	1.1k
Cara C. Boutte United States	15	600 0.9×	755 1.1×	510 1.0×	395 1.5×	209 0.8×	22	1.3k
Bhavna G. Gordhan South Africa	13	742 1.1×	391 0.6×	627 1.2×	154 0.6×	194 0.8×	33	1.1k
Nagraj Mani United States	18	588 0.9×	534 0.8×	309 0.6×	174 0.7×	151 0.6×	36	1.3k
Jun-Rong Wei United States	18	400 0.6×	562 0.8×	292 0.6×	235 0.9×	161 0.7×	31	976
Francesca Boldrin Italy	16	662 1.0×	456 0.7×	483 0.9×	142 0.5×	154 0.6×	32	1.0k
Luis R. Camacho Singapore	13	1.1k 1.6×	672 1.0×	918 1.7×	121 0.5×	214 0.9×	17	1.6k
Torin R. Weisbrod United States	17	1.4k 2.0×	868 1.3×	1.1k 2.1×	163 0.6×	368 1.5×	19	1.9k
Iona L. Bartek United States	9	561 0.8×	329 0.5×	459 0.9×	111 0.4×	175 0.7×	10	811

Countries citing papers authored by David Avarbock

Since Specialization

Citations

This map shows the geographic impact of David Avarbock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Avarbock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Avarbock more than expected).

Fields of papers citing papers by David Avarbock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Avarbock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Avarbock. The network helps show where David Avarbock may publish in the future.

Co-authorship network of co-authors of David Avarbock

This figure shows the co-authorship network connecting the top 25 collaborators of David Avarbock. A scholar is included among the top collaborators of David Avarbock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Avarbock. David Avarbock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Weinstein, Edward A., Takahiro Yano, Linsheng Li, et al.. (2005). Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proceedings of the National Academy of Sciences. 102(12). 4548–4553. 219 indexed citations

Avarbock, Andrew, David Avarbock, J. S. Teh, et al.. (2005). Functional Regulation of the Opposing (p)ppGpp Synthetase/Hydrolase Activities of Rel_Mtb from Mycobacterium tuberculosis. Biochemistry. 44(29). 9913–9923. 80 indexed citations

Dahl, John L., Carl Kraus, Helena I. Boshoff, et al.. (2003). The role of Rel _Mtb -mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proceedings of the National Academy of Sciences. 100(17). 10026–10031. 276 indexed citations

Kana, Bavesh D, Edward A. Weinstein, David Avarbock, et al.. (2001). Characterization of the cydAB -Encoded Cytochrome bd Oxidase from Mycobacterium smegmatis. Journal of Bacteriology. 183(24). 7076–7086. 123 indexed citations

Primm, Todd P., Susan J. Andersen, Valerie Mizrahi, et al.. (2000). The Stringent Response of Mycobacterium tuberculosis Is Required for Long-Term Survival. Journal of Bacteriology. 182(17). 4889–4898. 269 indexed citations

Avarbock, David, Andrew Avarbock, & Harvey Rubin. (2000). Differential Regulation of Opposing Rel_Mtb Activities by the Aminoacylation State of a tRNA·Ribosome·mRNA·Rel_Mtb Complex. Biochemistry. 39(38). 11640–11648. 88 indexed citations

Avarbock, David, et al.. (1999). Cloning and characterization of a bifunctional RelA/SpoT homologue from Mycobacterium tuberculosis. Gene. 233(1-2). 261–269. 89 indexed citations

Yang, Fude, S.C. Curran, David Avarbock, et al.. (1997). Characterization of two genes encoding the Mycobacterium tuberculosis ribonucleotide reductase small subunit. Journal of Bacteriology. 179(20). 6408–6415. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact